Linear partnerships were observed in between AUC0-- t and BPC157 dosages, in addition to in between Cmax and BPC157 dosages (Numbers 1D, E). The outright bioavailability after IM administration of each dose was 18.82%, 14.49%, and 19.35%, specifically. The previously mentioned outcomes revealed that BPC157 reached its peak rapidly in...